Related Experiment Video
Updated: Aug 8, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Incidence of Medication-Related Problems Following Pediatric Epilepsy Admissions
Jessica Kulawiak1, Joette Amundaray Miller1, Sara W Hovey1
1Department of Pharmacy, Rush University Medical Center, Chicago, Illinois.
Insights
Pediatric epilepsy patients experienced fewer medication problems after discharge with education, but the difference was not statistically significant. Education alone may not be sufficient to reduce medication errors in this vulnerable population.
Area of Science:
- Pediatric Neurology
- Pharmacology
- Patient Safety
Background:
- Medication errors at hospital discharge affect 26-33% of pediatric patients.
- Pediatric patients with epilepsy face heightened risks due to complex medication needs and frequent hospitalizations.
Purpose of the Study:
- To determine the rate of medication problems in pediatric epilepsy patients post-discharge.
- To assess the impact of discharge medication education on reducing these problems.
Main Methods:
- Retrospective cohort study comparing a control group with a group receiving discharge medication education (2:1 ratio).
- Medical records reviewed from discharge to outpatient follow-up for medication problems.
- Primary outcome: difference in medication problem proportion; secondary outcomes: harm potential, readmissions.
Main Results:
- Incidence of medication problems was 29.4% (control) vs. 24.1% (education), P=0.44.
- Medication problems with harm potential were 54.2% (control) vs. 28.6% (education), P=0.131.
- Most common issues involved dose or direction discrepancies.
Conclusions:
- Discharge medication education showed a trend toward reducing medication problems and harm potential in pediatric epilepsy patients, but differences were not statistically significant.
- Education alone may be insufficient to significantly impact medication error rates in this population, suggesting a need for multifaceted interventions.
Background:
An estimated 26% to 33% of pediatric patients have at least one medication error at hospital discharge. Pediatric patients with epilepsy may be at greater risk due to complex medication regimens and frequent hospitalizations. This study aims to quantify the proportion of pediatric patients with epilepsy experiencing medication problems after discharge and determine if medication education decreases these problems.
Methods:
This was a retrospective cohort study including pediatric patients with epilepsy-related hospital admissions. Cohort 1 consisted of a control group, and cohort 2 consisted of patients who received discharge medication education, enrolled in a 2:1 ratio. The medical record was reviewed from hospital discharge to outpatient neurology follow-up to identify medication problems that occurred. The primary outcome was the difference in proportion of medication problems between the cohorts. Secondary outcomes were incidence of medication problems with harm potential, overall incidence of medication problems, and 30-day epilepsy-related readmissions.
Results:
A total of 221 patients were included (163 in the control cohort and 58 in the discharge education cohort) with balanced demographics. The incidence of medication problems was 29.4% in the control cohort and 24.1% in the discharge education cohort (P = 0.44). The most common problems were mismatched dose or direction. Medication problems with harm potential were 54.2% in the control group and 28.6% in the discharge education cohort (P = 0.131).
Conclusion:
Medication problems and their harm potential were lower in the discharge education cohort, but the difference was not significant. This demonstrates education alone may not be enough to impact medication error rates.
More Related Videos
07:01Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
Related Concept Videos
Factors Affecting Drug Response: Overview
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists